Novel Crystalline Form of Lenvantinib Mesylate and Process of Preparation Thereof

• 收藏
• 分享

专利权人:

LTD.;CRYSTAL PHARMATECH CO.

发明人:

Minhua CHEN,Yanfeng ZHANG,Xiaojuan DIAO,Xiaoyu ZHANG

申请号：

US16364114

公开号：

US20190218184A1

申请日:

2019.03.25

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present disclosure relates to a novel crystalline form of lenvatinib mesylate and the preparation method thereof. The novel crystalline form of mesylate of the present disclosure can be used for treating invasive and differentiated thyroid cancer. The novel crystalline form of mesylate of the present disclosure has good solubility, stability, and remarkable purification effect in process. The preparation method of this novel crystalline form is simple, low cost, and has an important value for future optimization and development of the drug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/